Before you sell to, join or invest in EVIA Life Sciences Inc.
MentionFox check on EVIA Life Sciences Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/evia-life-sciences-inc-form-d-000001
Check EVIA Life Sciences Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about EVIA Life Sciences Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
EVIA Life Sciences Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-02.
EVIA Life Sciences Inc. filed a Form D notice of an exempt securities offering with the SEC on November 2, 2026. The filing reports $700K sold. Its industry group is Biotechnology. It names Kosuke Takishima (Executive Officer), Joshua Schwab (Director), Michael Kim (Director) (SEC Form D, November 2, 2026).
Selling to EVIA Life Sciences Inc.? See who runs it and how to reach them, plus this week's 43 other newly funded companies.
Is this your company?
Sell to companies like EVIA Life Sciences Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-11-02 · the record
Pitching, partnering or investing alongside them? See who really runs and owns EVIA Life Sciences Inc.
Free to see. No signup.
More on the people and the money behind EVIA Life Sciences Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when EVIA Life Sciences Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when EVIA Life Sciences Inc. raises, hires or launches. No email unless you switch it on.
Watch EVIA Life Sciences Inc. →Get the full cited report on EVIA Life Sciences Inc.
What the filing shows about EVIA Life Sciences Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on EVIA Life Sciences Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives EVIA Life Sciences Inc.'s address as Midtown Tower 18F, 9-7-1 Akasaka, Minato-Ku, Tokyo, M0 107-6218.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on EVIA Life Sciences Inc. See pricing
EVIA Life Sciences Inc. is a registered filer with the SEC (CIK 2162667) and has filed since 2026-11-02. 1 filing is on record, the latest on 2026-11-02.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
EVIA Life Sciences Inc.'s Form D of 2026-11-02 names Kosuke Takishima, Joshua Schwab, Michael Kim and 1 more as its officers, directors or promoters.
Its new offerings report $700K sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week. The dot is this raise, $700K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
Evia Life Sciences Inc, co-founded in 2020 by Dr. Takahiro Ochiya, develops innovative Extracellular Vesicle (EV)-based therapies.
The title and description the site itself served, answering 200, after redirecting from https://evialifesciences.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Kosuke Takishima is named as Executive Officer on the Form D that EVIA Life Sciences Inc. filed with the SEC on 2 November 2026, one of 4 people that filing names.
Joshua Schwab is named as Director on the Form D that EVIA Life Sciences Inc. filed with the SEC on 2 November 2026, one of 4 people that filing names.
Michael Kim is named as Director on the Form D that EVIA Life Sciences Inc. filed with the SEC on 2 November 2026, one of 4 people that filing names.
Takahiro Ochiya is named as Director on the Form D that EVIA Life Sciences Inc. filed with the SEC on 2 November 2026, one of 4 people that filing names.
4 people named on the filing — 1 holding an executive role and 3 as directors only.
Named as of the 2026-11-02 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about EVIA Life Sciences Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on EVIA Life Sciences Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on EVIA Life Sciences Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist EVIA Life Sciences Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind EVIA Life Sciences Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-04 (evialifesciences.com).
Each opens in a new tab, filled in for EVIA Life Sciences Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/evia-life-sciences-inc-form-d-000001